Shohei Koide, Ph.D. (小出昌平) is Professor of Biochemistry and Molecular Pharmacology at New York University School of Medicine and the Director of Cancer Biologics platform in the Perlmutter Cancer Center at NYU Langone Health.
He is an internationally recognized leader in protein engineering and design. He has made major contributions to the fundamental principles and technologies that enable the creation of synthetic proteins, i.e. proteins with novel functions that have never existed in nature. His current research focus is to develop next-generation therapeutics for most challenging cancers. His independent research group has been funded continuously by grants from the U.S. National Institutes of Health since 1997 (www.koidelab.org). He has published over 130 papers and holds 18 issued patents.
He received B.S., M.S. and Ph.D. from the University of Tokyo and received postdoctoral training at the Scripps Research Institute as a Human Frontier Science Program scholar. He was a member of the University of Tokyo rowing team (体育会漕艇部) and among the finalists in the qualifier for the Los Angeles Olympics. Previously he was Professor of Biochemistry and Molecular Biology at University of Chicago (2002-16) and Associate Professor of Biochemistry and Biophysics at University of Rochester School of Medicine and Dentistry (1995-2002).
He is an Elected Fellow of the American Association for the Advancement of Science and on the editorial boards of Journal of Molecular Biology and Protein Engineering, Design and Selection. He served as a Scientific Director of the Chicago Biomedical Consortium, a private funding agency that stimulates inter-institutional collaboration in the Chicago area.
